Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
CRF Health Enhances TrialManager for Intelligent eCOA Reporting & Data Visualization
Tuesday, May 31, 2016
CRF Health announces reporting enhancements to TrialManager®, its real-time portal for the analysis and management of data collected in clinical trials.
North West EHealth’s Unique Linked Database System Used in Salford Lung Study
Thursday, May 26, 2016
North West EHealth’s Unique Linked Database System ensures rapid patient recruitment and reduces clinical development time and costs.
CRF Health Launches TrialConsent, a TrialMax Platform Extension
Tuesday, May 17, 2016
CRF Health launches TrialConsent™, an industry-first electronic informed consent solution fully integrated within an eCOA platform
Centrifugal Evaporator for Contract Research Organisations
Monday, April 25, 2016
The EZ-2 Elite centrifugal evaporator from Genevac, an evaporator of choice for large Pharma R&D, uniquely combines high performance, versatility, ease-of-use and affordability making it the perfect workhorse system for Contract Research Organisations (CRO's).
Global Effort to Develop New Diabetes Treatment
Tuesday, April 12, 2016
CRF Health announces that its TrialMax® eCOA platform has been selected by a leading sponsor in the field of diabetes research.
Quotient Clinical Showcases Enabled-First-in-Human® Programs at ASCPT 2016
Wednesday, March 02, 2016
Quotient Clinical, the Translational Pharmaceutics® company, will be showcasing its Enabled-First-in-Human® (Enabled-FIH) programs at the upcoming American Society for Clinical Pharmacology and Therapeutics (ASCPT) Meeting 2016, to be held on the 8th to 12th of March in San Diego, California.
Portable High-Performance Rheometer Measures Fluids at High Pressures
Thursday, February 18, 2016
New HAAKE Viscotester iQ Rheometer adapts to varying demands of the petrochemical market.
New Chambers Designed to Provide Optimum Uniformity for Stable Environmental Conditions
Monday, February 15, 2016
Company has designed the Environmental Chambers which use a unique airflow system for advanced temperature control for drug stability testing, shelf-life testing, insect studies or controlled storage.
Klöckner Pentaplast at Pharmapack Europe
Thursday, February 04, 2016
Company explores BlisterPro® XCEL suite of services.
Showing Results 1 - 10 of 326
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA
The six-month study will enroll 60 to 120 EVD survivors.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to
modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,300+ scientific and medical posters
4,900+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!